Follow
Tereza Masonou
Title
Cited by
Cited by
Year
CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: a randomized, placebo-controlled trial
T Masonou, DA Hokey, T Lahey, A Halliday, LC Berrocal-Almanza, ...
PLoS One 14 (5), e0217091, 2019
232019
Cell-intrinsic differences between human airway epithelial cells from children and adults
EF Maughan, RE Hynds, A Pennycuick, E Nigro, KHC Gowers, C Denais, ...
Iscience 25 (11), 2022
152022
Immunodiagnosis of active tuberculosis
A Halliday, T Masonou, M Tolosa-Wright, V Mandagere, A Lalvani
Expert review of respiratory medicine 13 (6), 521-532, 2019
152019
Human models for COVID‐19 research
MNJ Woodall, T Masonou, KM Case, CM Smith
The Journal of Physiology 599 (18), 4255-4267, 2021
142021
Age-specific nasal epithelial responses to SARS-CoV-2 infection
MNJ Woodall, AM Cujba, KB Worlock, KM Case, T Masonou, M Yoshida, ...
Nature microbiology 9 (5), 1293-1311, 2024
82024
New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study
A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ...
Efficacy and Mechanism Evaluation 8 (5), 2021
42021
IL-1β turnover by the UBE2L3 ubiquitin conjugating enzyme and HECT E3 ligases limits inflammation
V Mishra, A Crespo-Puig, C McCarthy, T Masonou, I Glegola-Madejska, ...
Nature Communications 14 (1), 4385, 2023
32023
The emergence of goblet inflammatory or ITGB6hi nasal progenitor cells determines age-associated SARS-CoV-2 pathogenesis
M Woodall, AM Cujba, KB Worlock, KM Case, T Masonou, M Yoshida, ...
bioRxiv, 2023.01. 16.524211, 2023
22023
Defining the role of cellular immune signatures in diagnostic evaluation of suspected tuberculosis
A Halliday, T Masonou, MR Tolosa-Wright, Y Guo, L Hoang, R Parker, ...
The Journal of Infectious Diseases 225 (9), 1632-1641, 2022
22022
Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients
S Ellis, R Way, M Nel, A Burleigh, I Doykov, J Kembou-Ringert, M Woodall, ...
Mucosal Immunology 17 (1), 124-136, 2024
12024
IL-1β turnover by TRIP12 and AREL1 ubiquitin ligases and UBE2L3 limits inflammation
V Mishra, A Crespo-Puig, C McCarthy, T Masonou, I Glegola-Madejska, ...
bioRxiv, 2022.09. 14.507790, 2022
2022
Investigating neutrophil function during SARS-CoV2 infection in human airway epithelial cells from elderly and young individuals
T Masonou, M Woodall, E Robinson, A Eddaoudi, KM Case, JO Canseco, ...
European Respiratory Journal 60 (suppl 66), 2022
2022
Longevity and neutralisation activity of secretory IgA following SARS-CoV-2 infection
S Ellis, A Burleigh, R Way, J Kembou-Ringert, T Masonou, K Gilmour, ...
Access Microbiology 4 (5), po0272, 2022
2022
Cellular immune signatures
A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ...
New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study, 2021
2021
Transcriptomics
A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ...
New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study, 2021
2021
Candidate rule-out tests
A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ...
New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study, 2021
2021
Health economic analysis
A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ...
New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study, 2021
2021
Differential spatiotemporal targeting of Toxoplasma and Salmonella by GBP1 assembles caspase signalling platforms
D Fisch, B Clough, MC Domart, H Bando, T Masonou, LM Collinson, ...
2019
Validation of New Technologies for the Diagnostic Evaluation of Active Tuberculosis (VANTDET)
A Halliday
2018
Remdesivir and Nirmatrelvir Show Consistent Synergistic Efficacy Across Ancestral and Newly Emerged Sars-Cov-2 Clinical Isolates
M Woodall, S Ellis, S Zhang, J Kembou-Ringert, KA Kite, L Buggiotti, ...
Available at SSRN 4853574, 0
The system can't perform the operation now. Try again later.
Articles 1–20